dynein axonemal heavy chain 5
Last updated 22 Sept 2025
Meets Patient’s editorial guidelines
- DownloadDownload
- Share
- Language
- Discussion
- Ask Patient
- Audio Version
- Add to preferred sources on Google
The DNAH5 gene provides instructions for making a protein that is part of a larger group of proteins (a complex) called dynein. This complex functions within cell structures called cilia. Cilia are microscopic, finger-like projections that stick out from the surface of cells. They are found in cells that line the airway, the reproductive system, and many other organs and tissues. Coordinated back and forth movement of cilia can move the cell or the fluid surrounding the cell. Dynein makes up the structures (arms) that produce the force needed for cilia to move.
Video picks for GenesVideo library
Normal function
The DNAH5 gene provides instructions for making a protein that is part of a larger group of proteins (a complex) called dynein. This complex functions within cell structures called cilia. Cilia are microscopic, finger-like projections that stick out from the surface of cells. They are found in cells that line the airway, the reproductive system, and many other organs and tissues. Coordinated back and forth movement of cilia can move the cell or the fluid surrounding the cell. Dynein makes up the structures (arms) that produce the force needed for cilia to move.
Dynein forms structures known as inner dynein arms (IDAs) and outer dynein arms (ODAs) within the core of many cilia (the axoneme). Coordinated movement of the dynein arms causes the entire axoneme to bend back and forth. Within IDAs and ODAs, dynein is made up of different combinations of protein components (subunits) that are classified by weight as heavy, intermediate, or light chains. The DNAH5 gene provides instructions for making the heavy chain 5 protein, which is found in ODAs. Other subunits are produced from different genes.
Conditions referring to this gene or chromosome
Other names
DNAHC5
dynein heavy chain 5
dynein, axonemal, heavy chain 5
dynein, axonemal, heavy polypeptide 5
Patient picks for Genes

Drug interactions checker
Can I take Evana heavy period relief and Mefenamic acid together?
Taking these two medicines together significantly increases your risk of serious stomach problems, such as stomach ulcers, bleeding, or irritation of the stomach lining. It can also put extra strain on your kidneys.
Full body strength & conditioning exercises
Russian Kettlebell Swing
Improve hip power and glute strength with the Russian Kettlebell Swing. This exercise combines a hip hinge and swing motion, engaging your posterior chain muscles.
Full body strength & conditioning exercises
Pilates 100 with Legs Lifted
The Pilates 100 with Legs lifted is a challenging Full Body exercise. The exercise is performed 10 times with 5 inhales and 5 exhales equaling 100 repetitions. It is designed to improve all over body strength and stability as well as helping gain the most out of the movement with breath control.

Women's health
Heavy periods
Heavy periods are common. In most cases no cause can be found. In some cases a cause is found - these can include endometriosis, fibroids and other conditions. There are a number of ways of improving heavy periods and making them more manageable. Options include medication to reduce bleeding, use of an intra-uterine system (sometimes known as a hormonal coil) or an operation.
by Dr Philippa Vincent, MRCGP

Women's health
What causes heavy periods and abnormal vaginal bleeding?
Whether you're 13 or 53, abnormal or unexpected vaginal bleeding can be a massive source of stress, worry and confusion. But, while it could be an early sign of uterine or cervical cancer, it may also be a sign of something far more benign. The difficulty is knowing how to tell the difference! We speak to specialist gynae nurse Tracie Miles, from charity The Eve Appeal, to find out what your bleeding might be a symptom of, and when you should be concerned.
by Sarah Graham

Hay fever
How do hay fever tablets work?
Dr Sarah Jarvis MBE If your hay fever symptoms are not controlled on the medication that you are taking after 2-4 weeks, you should discuss this with your doctor. You may need to try a different treatment or add in another treatment. If you are taking hay fever medication regularly and your hay fever is well controlled on your current treatment, you should continue this treatment until the end of the pollen season. [https://patient.info/health/hay-fever-leaflet#nav-5](https://patient.info/health/hay-fever-leaflet#nav-5)
by Dr Sarah Jarvis
Related patient information and medicines

Patient information leaflet
Newborn bloodspot test
Mothers of all newborn babies are offered testing for certain rare but serious health conditions by testing blood taken from the baby's heel. This is the blood spot screening programme and it is also known as the heel prick test. How is the blood test done. This is usually done by a health professional (usually a midwife or health visitor) during.

Patient information leaflet
Myeloma
Myeloma is a cancer that affects cells, called plasma cells, in the bone marrow. Bone marrow is the spongy tissue at the centre of some bones that produces the body's blood cells. Dr Krishna Vakharia , 10th April 2025 The National Institute for Health and Care Excellence (NICE) has updated its guidance on assessment for myeloma in all ages.

Patient information leaflet
Kidney biopsy
A kidney biopsy involves taking a small sample of tissue from the kidney. Cells from the kidney can then be looked at in detail. It is used to diagnose and monitor certain conditions. Note : the information below is a general guide only. The arrangements, and the way tests are performed, may vary between different hospitals. Always follow the.

Patient information leaflet
IgA nephropathy
IgA nephropathy is a condition in which a protein causes damage to the kidneys. The protein is called immunoglobulin A or IgA. Nephropathy means an illness that damages the kidney. The main job of the kidneys is to clear waste materials from the body and maintain a normal balance of fluids and chemicals in the body. The kidneys also have other.

Patient information leaflet
Can I take Citalopram and Paracetamol together?
There is no known direct interaction between citalopram and paracetamol. It is generally considered safe to take these two medicines together at the recommended doses. Why this happens Citalopram (an antidepressant) and paracetamol (a painkiller) are processed by different pathways in the body and do not interfere with how the other works. What.

Patient information leaflet
Thalassaemia
There are different types, which vary from a mild condition to a serious or life-threatening condition. For the more severe forms of thalassaemia, modern treatment gives a good outlook, but lifelong monitoring and treatment are needed. Depending on which type you have, thalassaemia may cause no illness at all, or may be a serious lifelong.
Further reading and references
- dynein axonemal heavy chain 5; MedlinePlus, National Library of Medicine.
- Djakow J, Svobodova T, Hrach K, Uhlik J, Cinek O, Pohunek P. Effectiveness of sequencing selected exons of DNAH5 and DNAI1 in diagnosis of primary ciliary dyskinesia. Pediatr Pulmonol. 2012 Sep;47(9):864-75. doi: 10.1002/ppul.22520. Epub 2012 Mar 13.
- Dong M, Shi X, Zhou Y, Duan J, He L, Song X, Huang Z, Chen R, Li J, Jia N. Genetic spectrum and genotype-phenotype correlations in DNAH5-mutated primary ciliary dyskinesia: a systematic review. Orphanet J Rare Dis. 2025 Mar 3;20(1):97. doi: 10.1186/s13023-025-03596-5.
- Escudier E, Duquesnoy P, Papon JF, Amselem S. Ciliary defects and genetics of primary ciliary dyskinesia. Paediatr Respir Rev. 2009 Jun;10(2):51-4. doi: 10.1016/j.prrv.2009.02.001. Epub 2009 Apr 18.
- Failly M, Bartoloni L, Letourneau A, Munoz A, Falconnet E, Rossier C, de Santi MM, Santamaria F, Sacco O, DeLozier-Blanchet CD, Lazor R, Blouin JL. Mutations in DNAH5 account for only 15% of a non-preselected cohort of patients with primary ciliary dyskinesia. J Med Genet. 2009 Apr;46(4):281-6. doi: 10.1136/jmg.2008.061176.
- Hornef N, Olbrich H, Horvath J, Zariwala MA, Fliegauf M, Loges NT, Wildhaber J, Noone PG, Kennedy M, Antonarakis SE, Blouin JL, Bartoloni L, Nusslein T, Ahrens P, Griese M, Kuhl H, Sudbrak R, Knowles MR, Reinhardt R, Omran H. DNAH5 mutations are a common cause of primary ciliary dyskinesia with outer dynein arm defects. Am J Respir Crit Care Med. 2006 Jul 15;174(2):120-6. doi: 10.1164/rccm.200601-084OC. Epub 2006 Apr 20.
- Leigh MW, Pittman JE, Carson JL, Ferkol TW, Dell SD, Davis SD, Knowles MR, Zariwala MA. Clinical and genetic aspects of primary ciliary dyskinesia/Kartagener syndrome. Genet Med. 2009 Jul;11(7):473-87. doi: 10.1097/GIM.0b013e3181a53562.
- Lin HT, Gupta A, Bove KE, Szabo S, Xu F, Krentz A, Shillington AL. Novel Pathogenic DNAH5 Variants in Primary Ciliary Dyskinesia: Association with Visceral Heterotaxia and Neonatal Cholestasis. J Pediatr Genet. 2021 Aug 17;12(3):246-253. doi: 10.1055/s-0041-1733940. eCollection 2023 Sep.
- Olbrich H, Haffner K, Kispert A, Volkel A, Volz A, Sasmaz G, Reinhardt R, Hennig S, Lehrach H, Konietzko N, Zariwala M, Noone PG, Knowles M, Mitchison HM, Meeks M, Chung EM, Hildebrandt F, Sudbrak R, Omran H. Mutations in DNAH5 cause primary ciliary dyskinesia and randomization of left-right asymmetry. Nat Genet. 2002 Feb;30(2):143-4. doi: 10.1038/ng817. Epub 2002 Jan 14.
- Raidt J, Riepenhausen S, Pennekamp P, Olbrich H, Amirav I, Athanazio RA, Aviram M, Balinotti JE, Bar-On O, Bode SFN, Boon M, Borrelli M, Carr SB, Crowley S, Dehlink E, Diepenhorst S, Durdik P, Dworniczak B, Emiralioglu N, Erdem E, Fonnesu R, Gracci S, Grosse-Onnebrink J, Gwozdziewicz K, Haarman EG, Hansen CR, Hogg C, Holgersen MG, Kerem E, Korner RW, Kotz K, Kouis P, Loebinger MR, Lorent N, Lucas JS, Maj D, Mall MA, Marthin JK, Martinu V, Mazurek H, Mitchison HM, Nothe-Menchen T, Ozcelik U, Pifferi M, Pogorzelski A, Ringshausen FC, Roehmel JF, Rovira-Amigo S, Rumman N, Schlegtendal A, Shoemark A, Sperstad Kennelly S, Staar BO, Sutharsan S, Thomas S, Ullmann N, Varghese J, von Hardenberg S, Walker WT, Wetzke M, Witt M, Yiallouros P, Zschocke A, Zietkiewicz E, Nielsen KG, Omran H. Analyses of 1236 genotyped primary ciliary dyskinesia individuals identify regional clusters of distinct DNA variants and significant genotype-phenotype correlations. Eur Respir J. 2024 Aug 8;64(2):2301769. doi: 10.1183/13993003.01769-2023. Print 2024 Aug.
- Sironen A, Shoemark A, Patel M, Loebinger MR, Mitchison HM. Sperm defects in primary ciliary dyskinesia and related causes of male infertility. Cell Mol Life Sci. 2020 Jun;77(11):2029-2048. doi: 10.1007/s00018-019-03389-7. Epub 2019 Nov 28.
- Zariwala MA, Despotes KA, Davis SD. Primary Ciliary Dyskinesia. 2007 Jan 24 [updated 2025 May 22]. In: Adam MP, Bick S, Mirzaa GM, Wallace SE, Amemiya A, editors. GeneReviews(R) [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2026. Available from http://www.ncbi.nlm.nih.gov/books/NBK1122/
Share your thoughts or experiences with others in our patient communities.
Sign up to the Patient newsletter
Your weekly dose of clear, trustworthy health advice - written to help you feel informed, confident and in control.
By subscribing you accept our Privacy Policy. You can unsubscribe at any time. We never sell your data.

